Skip to main content

Advertisement

SpringerLink
Log in

A not entirely benign procedure: progression of Parkinson’s disease

  • Editorial
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Litvan I, Halliday G, Hallet M, Goetz CG, Rocca W, Duyckaerts Ch, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet M-F, Langston WJ, DiMonte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D, Price DL (2007) The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol 66:251–257

    PubMed  CAS  Google Scholar 

  2. Jellinger K, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. doi:10.1007/s00401-008-0347-5

  3. Lashley T, Holton JL, Gray E, Kirkham K, O’Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical α-synuclein load is associated with amyloid-βplaque burden in a subset of Parkinson’s disease patients. Acta Neuropathol. doi:10.1007/s00401-007-0336-0

  4. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

    Article  PubMed  Google Scholar 

  5. McKeith IG, Dickson DW, Lowe J, Emre E, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gómez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Korczyn A, Kosaka K, Lee VM-Y, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology 65:1863–1872

    Article  PubMed  CAS  Google Scholar 

  6. Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson’s disease. Acta Neuropathol. doi:10.1007/s00401-008-0344-8

  7. Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K (2008) α-Synuclein pathology in the neostriatum in Parkinson’s disease. Acta Neuropathol. doi:10.1007/s00401-007-0316-4

  8. Forno L (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc 17:557–575

    PubMed  CAS  Google Scholar 

  9. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F (1991) Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Adv Neurol 60:609–612

    Google Scholar 

  10. Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurol 12:284–295

    Article  CAS  Google Scholar 

  11. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Zeshan A, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is presymptomatic Parkinson’s disease. Acta Neuropathol. doi:10.1007/s00401-008-0345-7

  12. Uchihara T, Paulus W (2008) Research into neurodegenerative disease: an entangled web of mice and men. Acta Neuropathol 115:1–4

    Article  PubMed  Google Scholar 

  13. Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol. doi:10.1007/s00401-007-0313-7

  14. Parkkinen L, Pirttilä T, Alafuzoff I (2008) Applicability of current staging systems of α-synuclein pathology and their clinical relevance. Acta Neuropathol (in press)

  15. Halliday GM, McCann H (2008) Human-based studies on a-synuclein deposition and relationship to Parkinson’s disease symptoms. Exp Neurol 209:12–21

    Article  PubMed  CAS  Google Scholar 

  16. Braak H, Müller CM, Rüb U, Ackermann H, Bratzke H, de Vos RAI, Del Tredici K (2006) Pathology associated with sporadic Parkinson’s disease – where does it end? J Neural Trans Suppl 70:89–97

    Article  Google Scholar 

  17. Duda JE, Noorigian JV, Petrovitch H, White LR, Ross GW (2007) Pattern of Lewy pathology progression suggested by Braak staging system is supported by analysis of a population-based cohort of patients. The Movement Disorders Society’s 11th international congress late breaking abstracts, A3

  18. Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE (2008) Curcumin inhibits aggregation of a-synuclein. Acta Neuropathol. doi:10.1007/s00401-007-0332-4

  19. Van Den Eeden SK, Tanner CM, Berstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022

    Article  Google Scholar 

  20. Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007). Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 68:2012–2018

    Article  PubMed  CAS  Google Scholar 

  21. McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson’s disease. Ann Neurol 56:149–162

    Article  PubMed  CAS  Google Scholar 

  22. Beal F, Lang A (2006). The proteasomal inhibition model of Parkinson’s disease: “boon or bust”? Ann Neurol 60:158–161

    Article  PubMed  Google Scholar 

  23. Tofaris GK, Reitböck PG, Humby T, Lambourne SL, O’Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1–120): implications for Lewy body disorders. J Neurosci 26:3942–3950

    Article  PubMed  CAS  Google Scholar 

  24. Fleming SM, Fernagut P-O, Chesselet M-F (2005) Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2:495–503

    Article  PubMed  Google Scholar 

  25. Ulusoy A, Bjorklund T, Hermening S, Kirik D (2008) In vivo gene delivery for development of mammalian models for Parkinson’s disease. Exp Neurol 209:89–100

    Article  PubMed  CAS  Google Scholar 

  26. Meredith G, Sonsalla P, Chesselet M-F (2008) Animal models of Parkinson’s disease progression. Acta Neuropathol. doi:10.1007/s00401-008-0350-x

  27. Phillips RJ, Powley TL (2007) Innervation of the gastrointestinal tract: patterns in aging. Auton Neurosci 136:1–19

    Article  PubMed  Google Scholar 

  28. Miwa H, Kubo T, Suzuki A, Kondo T (2006) Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats. Neurosci Lett 401:46–149

    Article  CAS  Google Scholar 

  29. Phillips RJ, Powley T (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson’s disease? Neuroscience (in press)

  30. Moran LB, Hickey L, Michael GJ, Derkacs M, Christian LM, Kalaitzakis ME, Pearce RKB, Graeber M (2008) Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies. Acta Neuropathol. doi:10.2007/s00401-007-0309-3

  31. Thannickal TC, Lai Y-Y, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson’s disease. Brain 130:1586–1595

    Article  PubMed  Google Scholar 

  32. Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathol 27:494–506

    Article  Google Scholar 

  33. Wakabayashi K, Takahashi H, Obata K, Ikuta F (1992) Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson’s disease. Neurosci Lett 138:237–240

    Article  PubMed  CAS  Google Scholar 

  34. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 109:583–588

    Article  PubMed  Google Scholar 

  35. Braak H, Sandmann-Keil D, Gai W, Braak E (1999) Extensive axonal Lewy neurites in Parkinson’s disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 265:67–69

    Article  PubMed  CAS  Google Scholar 

  36. Duda JE, Giasson BI, Mahon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210

    Article  PubMed  CAS  Google Scholar 

  37. Duda JE (2004) Pathology and neurostransmitter abnormalities of dementia with Lewy bodies. Dement Geriatr Cogn Disord 17(Suppl 1):3–14

    Article  PubMed  CAS  Google Scholar 

  38. Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AL, Buchman VL, Anderton BH, Hanger DP (2003) Parkinson’s disease α-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci 117:1017–1024

    Article  CAS  Google Scholar 

  39. Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Del Tredici K (2006). Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord 21: 2042–2051

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the German Research Council (Deutsche Forschungsgemeinschaft) and Michael J. Fox Foundation for financial support. We also wish to thank Mr. Mohamed Bouzrou (immunohistochemistry) and Ms. Inge Szász-Jacobi (graphics) for their technical expertise.

Author information

Authors and Affiliations

  1. Institute for Clinical Neuroanatomy, J.W. Goethe University, Theodor Stern Kai 7, 60590, Frankfurt/Main, Germany

    Kelly Del Tredici & Heiko Braak

Authors
  1. Kelly Del Tredici
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heiko Braak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelly Del Tredici.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Del Tredici, K., Braak, H. A not entirely benign procedure: progression of Parkinson’s disease . Acta Neuropathol 115, 379–384 (2008). https://doi.org/10.1007/s00401-008-0355-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-008-0355-5

Keywords

Search

Navigation